Takeda Pharmaceutical Co., Ltd. (TAK)
18.28
+0.04
(+0.19%)
USD |
NYSE |
Aug 25, 12:31
Takeda Pharmaceutical Market Cap : 57.76B for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 57.65B |
| August 21, 2026 | 57.46B |
| August 20, 2026 | 57.30B |
| August 19, 2026 | 57.97B |
| August 18, 2026 | 57.05B |
| August 17, 2026 | 54.93B |
| August 14, 2026 | 55.72B |
| August 13, 2026 | 54.96B |
| August 12, 2026 | 55.03B |
| August 11, 2026 | 55.25B |
| August 10, 2026 | 55.47B |
| August 07, 2026 | 55.15B |
| August 06, 2026 | 53.79B |
| August 05, 2026 | 52.85B |
| August 04, 2026 | 52.34B |
| August 03, 2026 | 53.19B |
| July 31, 2026 | 54.01B |
| July 30, 2026 | 54.52B |
| July 29, 2026 | 56.10B |
| July 28, 2026 | 55.37B |
| July 27, 2026 | 55.10B |
| July 24, 2026 | 54.47B |
| July 23, 2026 | 53.15B |
| July 22, 2026 | 53.30B |
| July 21, 2026 | 54.44B |
| Date | Value |
|---|---|
| July 20, 2026 | 53.87B |
| July 17, 2026 | 54.19B |
| July 16, 2026 | 52.86B |
| July 15, 2026 | 51.98B |
| July 14, 2026 | 51.79B |
| July 13, 2026 | 52.10B |
| July 10, 2026 | 52.32B |
| July 09, 2026 | 52.48B |
| July 08, 2026 | 52.92B |
| July 07, 2026 | 53.59B |
| July 06, 2026 | 53.37B |
| July 02, 2026 | 52.99B |
| July 01, 2026 | 50.40B |
| June 30, 2026 | 50.65B |
| June 29, 2026 | 50.49B |
| June 26, 2026 | 50.27B |
| June 25, 2026 | 49.45B |
| June 24, 2026 | 49.67B |
| June 23, 2026 | 50.05B |
| June 22, 2026 | 48.88B |
| June 18, 2026 | 49.39B |
| June 17, 2026 | 48.72B |
| June 16, 2026 | 49.48B |
| June 15, 2026 | 49.83B |
| June 12, 2026 | 50.27B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Daiichi Sankyo Co., Ltd. | 32.77B |
| Ono Pharmaceutical Co., Ltd. | 7.176B |
| Astellas Pharma, Inc. | 26.97B |
| Sanofi | 111.04B |
| Eisai Co., Ltd. | 8.564B |
Market Cap Related Metrics
| PS Ratio | 1.945 |
| Price to Book Value | 1.242 |
| Price to Free Cash Flow | 21.66 |
| Price | 18.28 |
| Earnings Yield | -1.85% |
| Operating PE Ratio | 12.73 |